search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

DermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit

January 9, 2020

More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age and older. The US affiliate of BTL Aesthetics has filed suit against Allergan and Germany’s Zimmer MedizinSysteme in the US Federal District Court for the District of Delaware, asserting that the Cooltone device infringes on BTL's US patents. 

Advertisement

In This Series

View More

Advertisement